These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20369228)

  • 1. Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
    Kraus B; Wolff H; Elstner EF; Heilmann J
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):541-53. PubMed ID: 20369228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
    Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
    J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of STAT-1 inhibition and induction of cytokine resistance in pancreatic β cells treated with St John's wort and its component hyperforin.
    Novelli M; Beffy P; Gregorelli A; Porozov S; Mascia F; Vantaggiato C; Masiello P; Menegazzi M
    J Pharm Pharmacol; 2019 Jan; 71(1):93-103. PubMed ID: 28990659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study.
    Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC
    J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperforin and its analogues inhibit CYP3A4 enzyme activity.
    Lee JY; Duke RK; Tran VH; Hook JM; Duke CC
    Phytochemistry; 2006 Dec; 67(23):2550-60. PubMed ID: 17083953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L.
    Sosa S; Pace R; Bornancin A; Morazzoni P; Riva A; Tubaro A; Della Loggia R
    J Pharm Pharmacol; 2007 May; 59(5):703-9. PubMed ID: 17524236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hyperforin in the pharmacological activities of St. John's Wort.
    Zanoli P
    CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse.
    Cantoni L; Rozio M; Mangolini A; Hauri L; Caccia S
    Toxicol Sci; 2003 Sep; 75(1):25-30. PubMed ID: 12857935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
    J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
    Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
    Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
    Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Role of St. John's Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies.
    Novelli M; Masiello P; Beffy P; Menegazzi M
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
    Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
    J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
    Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
    FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.